Baker Hughes Company vs SLB Limited — Stock Comparison
Q·Score Breakdown
7.5
Bullish
Overall
7.1
Bullish
Quality
Health
Growth
Valuation
Sentiment
BKR
High-quality business with 17% return on equity and 11% profit margins.
⚠ valuation metrics above sector average.
SLB
Clean balance sheet with low leverage (0.4× debt-to-equity).
⚠ earnings contracting 14% year-over-year.
Analyst Consensus
BUY
Target $69.71 (+0.9%)
21 analysts
BUY
Target $60.33 (+6.0%)
28 analysts
Fundamentals
BKR
SLB
22.1×
Trailing P/E
25.1×
24.7×
Forward P/E
17.0×
11.2%
Profit Margin
9.3%
23.6%
Gross Margin
17.8%
17.2%
ROE
14.1%
2.5%
Revenue Growth
2.7%
132.5%
Earnings Growth
-13.8%
0.90
Beta
0.69
—
Price / Book
—
$68.6B
Market Cap
$85.1B
$36 – $70
52-Week Range
$32 – $57
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →